Vivoryon Therapeutics N.V. (LON:0R3M)
London flag London · Delayed Price · Currency is GBP · Price in EUR
1.798
+0.004 (0.22%)
At close: Apr 28, 2025

Vivoryon Therapeutics Market Cap

Vivoryon Therapeutics has a market cap or net worth of 39.26 million as of May 1, 2025. Its market cap has increased by 206.21% in one year.

Market Cap
39.26M
Enterprise Value
31.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.80

Market Cap Chart

Since October 27, 2014, Vivoryon Therapeutics's market cap has decreased from 106.65M to 39.26M, a decrease of -63.19%. That is a compound annual growth rate of -9.07%.

History

DateMarket Cap% Change
Apr 30, 202539.26M-8.48%
Dec 31, 202442.90M-76.70%
Dec 29, 2023184.13M-16.55%
Dec 30, 2022220.65M-30.94%
Dec 31, 2021319.49M98.13%
Dec 31, 2020161.25M75.13%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 163.22B
GSK plc 57.05B
Haleon 33.97B
Smith & Nephew 8.73B
ConvaTec Group 5.23B
Hikma Pharmaceuticals 4.27B
HUTCHMED (China) 1.92B
Oxford Nanopore Technologies 1.12B
Market Cap Rankings